CLINICAL_TRIALS
trial_result
· 2022-10-25
Clinical Trial Update: Accelerated Hypofractionated 1 Week Radiotherapy in Breast Cancer Patients [Phase 3]
Summary
Phase 3 trial update on Accelerated Hypofractionated 1 Week Radiotherapy in breast cancer patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Zagazig University | Conditions: Breast Cancer Radiotherapy | Phase 3 | Status: COMPLETED